2017 International Congress Archives - Page 150 of 155

Using cognitive computing to identify compounds with antidyskinetic potential for Parkinson’s disease

N. Visanji, A. Lacoste, S. Ezell, S. Spangler, E. Argentinis, J. Brotchie, A. Lang, T. Johnston (Toronto, ON, Canada)
Using eye tracking to identify pupil and saccade biomarkers of neurodegenerative disease

D. Munoz, B. Coe, J. Huang, M. Smorenburg, D. Brien, S. Black, M. Borrie, D. Dowlatshahi, E. Finger, D. Grimes, M. Freedman, A. Lang, C. Marras, M. Masellis, R. Swartz, C. Tartaglia, L. Zinman, t. ONDRI Investigators (Kingston, ON, Canada)
Using measurements from wearable sensors for automatic scoring of Parkinson’s disease motor states

I. Thomas, F. Bergquist, R. Constantinescu, D. Nyholm, M. Senek, M. Memedi (Falun, Sweden)
Using the power of a Network to accomplish a Countrywide Review of Acute Parkinson’s Disease management

E. Peter, B. Mohamed, C. Thomas (Bridgend, United Kingdom)
Utility of ataxia gene panel testing in diagnosing inherited ataxia: evaluation of an Irish cohort

P. Bogdanova-Mihaylova, R. Walsh, S. Murphy (Dublin 24,, Ireland)
Utility of DaTscan Imaging in Differentiating Drug Induced Parkinsonism from IPD and Other Forms of Parkinsonism

M. Salgado, D. Panebianco, J. Muller, A. Ortega, S. (Brooklyn, NY, USA)
Utility of susceptibility weighted imaging in the objective diagnosis of idiopathic Parkinson’s Disease: Is DaTscan necessary?

R. Ellis, M. Radon, M. Bonello, M. Steiger (Liverpool, United Kingdom)
Utility of THK-5351 tau-PET for differential diagnosis in patients with hypokinetic-rigid syndromes.

G. Rohrer, S. Schönecker, M. Brendel, J. Havla, G. Höglinger, S. Lindner, C. Zach, F. Vettermann, C. Prix, G. Nübling, P. Bartenstein, K. Furukawa, A. Ishiki, N. Okamura, K. Bötzel, A. Rominger, J. Levin (Munich, Germany)
Validation of a performance-based assessment of functional ability related to cognition in Parkinson’s disease

S. Holden, L. Medina, B. Hoyt, S. Sillau, J. Goldman, D. Weintraub, B. Kluger (Aurora, CO, USA)
Validation of actigraphy-derived sleep metrics in Parkinson’s disease (PD) patients and elderly controls, taking into account clinical and physiological status

J. Munro, R. Wolz, D. Hill, Y. DAUVILLIERS (London, United Kingdom)